Osteopontin is increased in HIV-associated dementia

Tricia H. Burdo, Ronald J. Ellis, Howard S Fox

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Since the introduction of highly active antiretroviral therapy, survival rates for human immunodeficiency virus (HIV) infection have markedly improved, but less of an effect has been found for HIV-associated neurocognitive disorders. On the basis of our previous findings, we hypothesized that increased production of osteopontin might contribute to the persistence of central nervous system (CNS) dysfunctions. We found increased levels of osteopontin in the brains of humans withHIVencephalitis and monkeys with simian immunodeficiency virus (SIV) encephalitis. In cerebrospinal fluid, osteopontin levels were found to be elevated in HIV-infected individuals, regardless of their neuropsychological status. However, plasma osteopontin levels were significantly increased in individuals with HIV-associated dementia. In addition, a longitudinal study of monkeys revealed that plasma levels of osteopontin increased before the development of SIV-induced neurological and clinical abnormalities. Thus, plasma levels of osteopontin are significantly correlated with HIV-induced CNS dysfunction in the current era of efficacious antiviral treatment, and this finding suggests that the development of interventions to modulate osteopontin production or signaling might be beneficial in the prevention or treatment of HIV-induced CNS disorders.

Original languageEnglish (US)
Pages (from-to)715-722
Number of pages8
JournalJournal of Infectious Diseases
Volume198
Issue number5
DOIs
StatePublished - Sep 1 2008

Fingerprint

Osteopontin
Dementia
HIV
Simian Immunodeficiency Virus
Haplorhini
Central Nervous System
Central Nervous System Diseases
Highly Active Antiretroviral Therapy
Virus Diseases
Encephalitis
Antiviral Agents
Longitudinal Studies
Cerebrospinal Fluid
Brain
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Osteopontin is increased in HIV-associated dementia. / Burdo, Tricia H.; Ellis, Ronald J.; Fox, Howard S.

In: Journal of Infectious Diseases, Vol. 198, No. 5, 01.09.2008, p. 715-722.

Research output: Contribution to journalArticle

Burdo, Tricia H. ; Ellis, Ronald J. ; Fox, Howard S. / Osteopontin is increased in HIV-associated dementia. In: Journal of Infectious Diseases. 2008 ; Vol. 198, No. 5. pp. 715-722.
@article{ef49c713ab1244ddbf457f4d866791eb,
title = "Osteopontin is increased in HIV-associated dementia",
abstract = "Since the introduction of highly active antiretroviral therapy, survival rates for human immunodeficiency virus (HIV) infection have markedly improved, but less of an effect has been found for HIV-associated neurocognitive disorders. On the basis of our previous findings, we hypothesized that increased production of osteopontin might contribute to the persistence of central nervous system (CNS) dysfunctions. We found increased levels of osteopontin in the brains of humans withHIVencephalitis and monkeys with simian immunodeficiency virus (SIV) encephalitis. In cerebrospinal fluid, osteopontin levels were found to be elevated in HIV-infected individuals, regardless of their neuropsychological status. However, plasma osteopontin levels were significantly increased in individuals with HIV-associated dementia. In addition, a longitudinal study of monkeys revealed that plasma levels of osteopontin increased before the development of SIV-induced neurological and clinical abnormalities. Thus, plasma levels of osteopontin are significantly correlated with HIV-induced CNS dysfunction in the current era of efficacious antiviral treatment, and this finding suggests that the development of interventions to modulate osteopontin production or signaling might be beneficial in the prevention or treatment of HIV-induced CNS disorders.",
author = "Burdo, {Tricia H.} and Ellis, {Ronald J.} and Fox, {Howard S}",
year = "2008",
month = "9",
day = "1",
doi = "10.1086/590504",
language = "English (US)",
volume = "198",
pages = "715--722",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Osteopontin is increased in HIV-associated dementia

AU - Burdo, Tricia H.

AU - Ellis, Ronald J.

AU - Fox, Howard S

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Since the introduction of highly active antiretroviral therapy, survival rates for human immunodeficiency virus (HIV) infection have markedly improved, but less of an effect has been found for HIV-associated neurocognitive disorders. On the basis of our previous findings, we hypothesized that increased production of osteopontin might contribute to the persistence of central nervous system (CNS) dysfunctions. We found increased levels of osteopontin in the brains of humans withHIVencephalitis and monkeys with simian immunodeficiency virus (SIV) encephalitis. In cerebrospinal fluid, osteopontin levels were found to be elevated in HIV-infected individuals, regardless of their neuropsychological status. However, plasma osteopontin levels were significantly increased in individuals with HIV-associated dementia. In addition, a longitudinal study of monkeys revealed that plasma levels of osteopontin increased before the development of SIV-induced neurological and clinical abnormalities. Thus, plasma levels of osteopontin are significantly correlated with HIV-induced CNS dysfunction in the current era of efficacious antiviral treatment, and this finding suggests that the development of interventions to modulate osteopontin production or signaling might be beneficial in the prevention or treatment of HIV-induced CNS disorders.

AB - Since the introduction of highly active antiretroviral therapy, survival rates for human immunodeficiency virus (HIV) infection have markedly improved, but less of an effect has been found for HIV-associated neurocognitive disorders. On the basis of our previous findings, we hypothesized that increased production of osteopontin might contribute to the persistence of central nervous system (CNS) dysfunctions. We found increased levels of osteopontin in the brains of humans withHIVencephalitis and monkeys with simian immunodeficiency virus (SIV) encephalitis. In cerebrospinal fluid, osteopontin levels were found to be elevated in HIV-infected individuals, regardless of their neuropsychological status. However, plasma osteopontin levels were significantly increased in individuals with HIV-associated dementia. In addition, a longitudinal study of monkeys revealed that plasma levels of osteopontin increased before the development of SIV-induced neurological and clinical abnormalities. Thus, plasma levels of osteopontin are significantly correlated with HIV-induced CNS dysfunction in the current era of efficacious antiviral treatment, and this finding suggests that the development of interventions to modulate osteopontin production or signaling might be beneficial in the prevention or treatment of HIV-induced CNS disorders.

UR - http://www.scopus.com/inward/record.url?scp=50949133939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949133939&partnerID=8YFLogxK

U2 - 10.1086/590504

DO - 10.1086/590504

M3 - Article

C2 - 18616394

AN - SCOPUS:50949133939

VL - 198

SP - 715

EP - 722

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -